Scintigraphic visualization of inflammation in neurodegenerative disordersVersijpt, J., Van Laere, K., Dierckx, RA., Dumont, F., De Deyn, PP., Slegers, G. & Korf, J., Feb-2003, In : Nuclear Medicine Communications. 24, 2, p. 209-221 13 p.
Research output: Contribution to journal › Review article › Academic › peer-review
In the past few decades, our understanding of the central nervous system has evolved from one of an immune-privileged site, to one where inflammation is pathognomonic for some of the most prevalent and tragic neurodegenerative diseases. Current research indicates that diseases as diverse as multiple sclerosis, stroke and Alzheimer's disease exhibit inflammatory processes that contribute to cellular dysfunction or loss. Inflammation, whether in the brain or periphery, is almost always a secondary response to a primary pathogen. In head trauma, for example, the blow to the head is the primary event. What typically concerns the neurologist and neurosurgeon more, however, is the secondary inflammatory response that will ensue and likely cause more neuron loss than the initial injury. This paper reviews the basic neuroinflammatory mechanisms, the potential neurotoxic mediators during activation of microglia, the brain resident macrophages, and their role in neurodegeneration. Alzheimer's disease is taken as a prototype for exploring these mechanisms, as it expresses more than 40 inflammatory mediators, it is the most extensively studied disorder in terms of immune-related pathogenesis, and because of its importance as the most prevalent type of dementia. Tools for the visualization of these neuroinflammatory processes, both structural and mainly functional, are critically reviewed and discussed. ((C) 2003 Lippincott Williams Wilkins).
|Number of pages||13|
|Journal||Nuclear Medicine Communications|
|Publication status||Published - Feb-2003|
- inflammation, microglia, neurodegenerative disorders, peripheral benzodiazepine receptor, PK11195, CENTRAL-NERVOUS-SYSTEM, POSITRON-EMISSION-TOMOGRAPHY, TUMOR-NECROSIS-FACTOR, BENZODIAZEPINE BINDING-SITE, IMMUNE-MEDIATED DISEASES, PROTON MR SPECTROSCOPY, NITRIC-OXIDE SYNTHASE, AMYLOID-BETA-PROTEIN, ALZHEIMERS-DISEASE, PERIPHERAL BENZODIAZEPINE